Literature DB >> 11025473

Concurrent Langerhans cell histiocytosis and myelodysplasia in children.

G Surico1, P Muggeo, N Rigillo, H Gadner.   

Abstract

BACKGROUND: Langerhans cell histiocytosis (LCH) is characterized by the proliferation of abnormal histiocytes (Langerhans cells), whose origin as a reactive process or a neoplastic disorder is still poorly understood. Although LCH has been recorded as being associated with malignant neoplasms, concurrence of LCH and myelodysplastic syndrome has not been reported so far. PROCEDURE: We report on four children aged 23, 25, 26, and 53 months with multisystem LCH with organ dysfunction (bone marrow and liver) whose bone marrow pictures, taken at diagnosis, revealed the presence of myelodysplastic abnormalities (RA, RAEB, RAEB-t).
RESULTS: We suggest that the commonly used expression of "organ dysfunction," which refers to clinical and functional alterations, could be explained by a myelodysplastic-like disorder.
CONCLUSIONS: The contemporary presence of both events may provide a better understanding of the pathogenesis of LCH, especially in young children with multisystem disease and organ dysfunction, who are known to have a very poor outcome. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11025473     DOI: 10.1002/1096-911x(20001001)35:4<421::aid-mpo5>3.0.co;2-h

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

1.  First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation.

Authors:  Christopher J Fraser; Betsy A Hirsch; Vanessa Dayton; Michael H Creer; Joseph P Neglia; John E Wagner; K Scott Baker
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis.

Authors:  Maria Laura Galluzzo; Jorge Braier; Sergio D Rosenzweig; Maria T Garcia de Dávila; Diego Rosso
Journal:  Pediatr Dev Pathol       Date:  2010 Mar-Apr

Review 3.  Cell(s) of Origin of Langerhans Cell Histiocytosis.

Authors:  Matthew Collin; Venetia Bigley; Kenneth L McClain; Carl E Allen
Journal:  Hematol Oncol Clin North Am       Date:  2015-08-20       Impact factor: 3.722

Review 4.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.